Spotlight: The Partnership for Safe Medicines (PSM)
This column is the third in a new series that puts a spotlight on causes and organizations that affect FDA and its stakeholders. Today’s Spotlight is on the Partnership for Safe Medicines (PSM), which plays a vital role in protecting American consumers from counterfeit and contraband medicines.
Given the size of the US pharmaceutical market and the complexity of the supply chain, the threat of harm from counterfeit products is substantial even though only a small percentage of drugs are compromised.
FDA Matters provides short-form analysis of FDA policy and regulatory issues. We know you are busy, so we publish 1 to 2 columns per week, each a 3-5 minute read.
FDA Matters does not report the news….we provide analysis of what’s behind the news.
FDA Matters advocates for a more effective, efficient, and fair FDA.
FDA Matters has been featured in:
Compounding, Patient Safety, and the Vital Role of FDA Enforcement
Over the last two years, few FDA topics have consumed more sustained attention than the mass compounding of commercially available drugs. GLP-1 (glucagon-like peptide-1 receptor agonists) drugs have been the focus of most of the public discussion. However, our…
Spotlight: Americans for Medical Progress/Vital Role of Animals in Research
Dear FDA Matters readers: This column is the second in a new series that puts a spotlight on causes and organizations that affect FDA and the FDA stakeholder community. The first (here) was on the Advanced Research Projects Agency-Health (ARPA-H). Another spotlight…
Speeding Innovative Medicines to Market: Any Delay Matters to Patients
FDA Commissioner Makary has embraced the cause of faster review times for drugs and biologics, an area that holds great promise for bringing innovative drugs to patients more quickly.1 While laudable and likely to succeed, faster drug review times are just one way to…
Spotlight: Advanced Research Projects Agency for Health (ARPA-H)
Dear FDA Matters readers: This column is the first in a new series that puts a spotlight on causes and organizations that affect FDA and the FDA stakeholder community. I have a second spotlight column in process and am open to recommendations for future topics. Steven…
Squaring the Circle: The Seemingly Impossible Task of Fixing the US Food Supply
There are so many interlocking and competing interests in food that it is hard to reach agreement on goals, let alone a plan for a future food system that is more coherent, effective, and better suited to each of our individual needs, desires, and situations….
RFK Jr.’s Anti-Vaccine Stance Infiltrated FDA. Trump Is Reining It In.
This week’s FDA Matters column is entitled: “RFK Jr.’s Anti-Vaccine Stance Infiltrated FDA. Trump Is Reining It In.” It was published in MedPage Today at https://www.medpagetoday.com/opinion/second-opinions/120041?trw=no. They subtitled the article:…